Pfizer (PFE)

If you are trying to generate income in retirement, these three high-yield healthcare stocks could be the perfect fit for you.

Look for names that tend to trade independently of the overall market, and don't be afraid to achieve some income growth.

GoodRx (GDRX) Q1 2026 Earnings Call Transcript

The competition is far behind.

Eli Lilly has a lofty valuation thanks to its strong GLP-1 growth, but don't count out these two competitors.

Animal health company Zoetis (NYSE:ZTS) missed Wall Street’s revenue expectations in Q1 CY2026 as sales only rose 1.9% year on year to $2.26 billion. The com...

Medication company Viatris (NASDAQ:VTRS) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 8.1% year on year to $3.52 bil...

Is Pfizer a yield trap? No way.

Investors often move like lemmings in the short term, giving long-term investors an opportunity to buy great companies.

Novavax (NVAX) Q1 2026 Earnings Transcript

Vaccine biotechnology company Novavax (NASDAQ:NVAX) beat Wall Street’s revenue expectations in Q1 CY2026, but sales fell by 79.1% year on year to $139.5 mill...

Global pharmaceutical company Pfizer (NYSE:PFE) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 5.4% year on year to $14.45 ...

Just because a dividend stock has suffered a significant stumble doesn't mean the setback is permanent. It doesn't even mean its dividend is in jeopardy.

Pfizer (PFE) Q1 2026 Earnings Transcript

Pfizer beats Q1 estimates with revenue growth and strong pipeline progress, extends Vyndamax patent outlook, and backs 2026 guidance.

US stocks rise, Dow gains 300 points. Materials jump 1.8%, real estate falls 0.2%. Pfizer's Q1 earnings beat expectations. Asian markets close lower.

Global pharmaceutical company Pfizer (NYSE:PFE) announced better-than-expected revenue in Q1 CY2026, with sales up 5.4% year on year to $14.45 billion. On th...

Pfizer delivered better-than-expected sales and profit.

US stock futures up, key stocks to watch today: Pfizer, Pinterest, PayPal, ON Semiconductor, AMD. Check out Benzinga Pro's premarket coverage.

Pfizer and Arvinas secure FDA approval for VEPPANU (vepdegestrant), a first-of-its-kind treatment for ESR1-mutated advanced breast cancer.

Eli Lilly stock toppled Monday after a patient taking its new weight-loss pill, Foundayo, experienced liver failure.

Pfizer to release Q3 earnings on May 5, with analysts expecting 72 cents/share and a revenue of $13.8 billion. Annual dividend yield at 6.53%.